SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-23-000019
Filing Date
2023-03-01
Accepted
2023-03-01 16:09:34
Documents
14
Period of Report
2023-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20230301.htm   iXBRL 8-K 32497
2 EX-99.1 q42022earningsrelease.htm EX-99.1 107767
  Complete submission text file 0001370053-23-000019.txt   330970

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20230301.xsd EX-101.SCH 2175
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20230301_def.xml EX-101.DEF 8981
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20230301_lab.xml EX-101.LAB 33134
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20230301_pre.xml EX-101.PRE 20654
8 EXTRACTED XBRL INSTANCE DOCUMENT anab-20230301_htm.xml XML 10999
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 23693547
SIC: 2834 Pharmaceutical Preparations